MQSA Inspection Information Related to COVID-19

The U.S. Food and Drug Administration (FDA) has received numerous inquiries about COVID-19 and its increasing impact on mammography facilities. Accordingly, we are providing information about common scenarios that may arise due to the evolving COVID-19 situation in the United States. Please see the revised policy regarding medical physicist survey extensions.

Read More